Characteristics and economic burden of hospitalized patients with herpes zoster in China, before vaccination

References

• Le P, Rothberg M. Herpes zoster infection. BMJ. 2019;364:k5095. doi:10.1136/bmj.k5095.
   PubMed Web of Science ®Google Scholar
• Schmader K. Herpes zoster. Ann Intern Med. 2018;169(12):ITC19–9. doi:10.7326/AITC201808070.
   PubMed Web of Science ®Google Scholar
• Amjadi O, Rafiei A, Haghshenas M, Navaei RA, Valadan R, Hosseini-Khah Z, Omran AH, Arabi M, Shakib RJ, Mousavi T, et al. A systematic review and meta-analysis of seroprevalence of varicella zoster virus: a nationwide population-based study. J Clin Virol. 2017;87:49–59. doi:10.1016/j.jcv.2016.12.001.
   PubMed Web of Science ®Google Scholar
• Bardach AE, Palermo C, Alconada T, Sandoval M, Balan DJ, Nieto Guevara J, Gómez J, Ciapponi A. Herpes zoster epidemiology in Latin America: a systematic review and meta-analysis. PloS One. 2021;16(8):e0255877. doi:10.1371/journal.pone.0255877.
   PubMed Web of Science ®Google Scholar
• Kridin K, Cohen AD. The underestimated risk for complications in immunocompetent patients with herpes zoster: should we change our clinical practice? Br J Dermatol. 2021;184(6):994–5. doi:10.1111/bjd.19860.
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open. 2014;4(6):e004833. doi:10.1136/bmjopen-2014-004833.
   PubMed Web of Science ®Google Scholar
• Drolet M, Brisson M, Schmader KE, Levin MJ, Johnson R, Oxman MN, Patrick D, Blanchette C, Mansi JA. The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study. CMAJ. 2010;182(16):1731–6. doi:10.1503/cmaj.091711.
   PubMed Web of Science ®Google Scholar
• Du J, Sun G, Ma H, Xiang P, Guo Y, Deng Y, Li S, Li X. Prevalence and risk factors of anxiety and depression in patients with postherpetic neuralgia: a retrospective study. Dermatology. 2021;237(6):891–5. doi:10.1159/000512190.
   PubMed Web of Science ®Google Scholar
• Schlereth T, Heiland A, Breimhorst M, Fechir M, Kern U, Magerl W, Birklein F. Association between pain, central sensitization and anxiety in postherpetic neuralgia. Eur J Pain. 2015;19(2):193–201. doi:10.1002/ejp.537.
   PubMed Web of Science ®Google Scholar
• Li H, Li X, Wang J, Gao F, Wiech K, Hu L, Kong Y. Pain-related reorganization in the primary somatosensory cortex of patients with postherpetic neuralgia. Hum Brain Mapp. 2022;43(17):5167–79. doi:10.1002/hbm.25992.
   PubMed Web of Science ®Google Scholar
• Ting DSJ, Ghosh N, Ghosh S. Herpes zoster ophthalmicus. BMJ. 2019;364:k5234. doi:10.1136/bmj.k5234.
   PubMedGoogle Scholar
• Freund PR, Chen SH. Herpes zoster ophthalmicus. CMAJ. 2018;190(21):E656. doi:10.1503/cmaj.180063.
   PubMed Web of Science ®Google Scholar
• Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013;369(3):255–63. doi:10.1056/NEJMcp1302674.
   PubMed Web of Science ®Google Scholar
• Chen MH, Wei HT, Su TP, Li CT, Lin WC, Chang WH, Chen T-J, Bai Y-M. Risk of depressive disorder among patients with herpes zoster: a nationwide population-based prospective study. Psychosom Med. 2014;76(4):285–91. doi:10.1097/PSY.0000000000000051.
   PubMed Web of Science ®Google Scholar
• Pickering G, Leplege A. Herpes zoster pain, postherpetic neuralgia, and quality of life in the elderly. Pain Pract. 2011;11:397–402. doi:10.1111/j.1533-2500.2010.00432.x.
   PubMed Web of Science ®Google Scholar
• Paek E, Johnson R. Public awareness and knowledge of herpes zoster: results of a global survey. Gerontology. 2010;56(1):20–31. doi:10.1159/000240046.
   PubMed Web of Science ®Google Scholar
• Gater A, Uhart M, McCool R, Preaud E. The humanistic, economic and societal burden of herpes zoster in Europe: a critical review. BMC Public Health. 2015;15(1):193. doi:10.1186/s12889-015-1514-y.
   PubMedGoogle Scholar
• Harvey M, Prosser LA, Rose AM, Ortega-Sanchez IR, Harpaz R. Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition. Pain. 2020;161(2):361–8. doi:10.1097/j.pain.0000000000001718.
   PubMed Web of Science ®Google Scholar
• Sun X, Wei Z, Lin H, Jit M, Li Z, Fu C. Incidence and disease burden of herpes zoster in the population aged ≥50 years in China: data from an integrated health care network. J Infect. 2021;82(2):253–60. doi:10.1016/j.jinf.2020.12.013.
   PubMed Web of Science ®Google Scholar
• Mick G. Vaccination: a new option to reduce the burden of herpes zoster. Expert Rev Vaccines. 2010;9:31–5. doi:10.1586/erv.10.32.
   PubMed Web of Science ®Google Scholar
• Chen P, Huang J, Li S, Tang Y, Xiao Y, Zou B, Chen X, Li J, Zhao Z, Shen M, et al. Nitrogen dioxide and hospital length of stay and cost for systemic lupus erythematosus in Hunan, China. Sci Total Environ. 2023;856:159013. doi:10.1016/j.scitotenv.2022.159013.
   PubMed Web of Science ®Google Scholar
• Deng X, Zou B, Li S, Wu J, Yao C, Shen M, Chen J, Li S. Disease specific air quality health index (AQHI) for spatiotemporal health risk assessment of multi-air pollutants. Environ Res. 2023;231:115943. doi:10.1016/j.envres.2023.115943.
   PubMed Web of Science ®Google Scholar
• Yang J, Wan SQ, Huang L, Zhong WJ, Zhang BL, Song J, Ma Y-H, Hu M. Analysis of hospitalization costs and length of stay for oral cancer patients undergoing surgery: evidence from Hunan, China. Oral Oncol. 2021;119:105363. doi:10.1016/j.oraloncology.2021.105363.
   PubMed Web of Science ®Google Scholar
• Weinberg A, Canniff J, Rouphael N, Mehta A, Mulligan M, Whitaker JA, Levin MJ. Varicella-zoster virus–specific cellular immune responses to the live attenuated zoster vaccine in young and older adults. J Immunol. 2017;199(2):604–12. doi:10.4049/jimmunol.1700290.
   PubMed Web of Science ®Google Scholar
• Arvin A. Aging, immunity, and the varicella–zoster virus. N Engl J Med. 2005;352(22):2266–7. doi:10.1056/NEJMp058091.
   PubMed Web of Science ®Google Scholar
• Varghese L, Standaert B, Olivieri A, Curran D. The temporal impact of aging on the burden of herpes zoster. BMC Geriatr. 2017;17(1):30. doi:10.1186/s12877-017-0420-9.
   PubMedGoogle Scholar
• Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc. 2017;92:1806–21. doi:10.1016/j.mayocp.2017.10.009.
   PubMed Web of Science ®Google Scholar
• Qian J, Lassere MN, Heywood AE, Liu B. Use of disease-modifying antirheumatic drugs and the subsequent risk of herpes zoster in older adults. Rheumatology (Oxford). 2021;60(11):5042–51. doi:10.1093/rheumatology/keab538.
   PubMed Web of Science ®Google Scholar
• Diez-Domingo J, Curran D, Cambronero MDR, Garcia-Martinez JA, Matthews S. Economic burden and impact on quality of life of herpes zoster in Spanish adults aged 50 years or older: a prospective cohort study. Adv Ther. 2021;38(6):3325–41. doi:10.1007/s12325-021-01717-7.
   PubMed Web of Science ®Google Scholar
• Rampakakis E, Pollock C, Vujacich C, Toniolo Neto J, Ortiz Covarrubias A, Monsanto H, Johnson, KD. Economic burden of herpes zoster (“culebrilla”) in Latin America. Int J Infect Dis. 2017;58:22–6. doi:10.1016/j.ijid.2017.02.021.
   PubMed Web of Science ®Google Scholar
• Esteban-Vasallo MD, Dominguez-Berjon MF, Gil-Prieto R, Astray-Mochales J, Gil de Miguel A. Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain). Hum Vaccines Immunother. 2014;10(6):1650–60. doi:10.4161/hv.28620.
   PubMed Web of Science ®Google Scholar
• Onizuka H, Fukuda H. Associations between income changes and the risk of herpes zoster: LIFE study. Social Sci Med. 2023;328:115981. doi:10.1016/j.socscimed.2023.115981.
   PubMed Web of Science ®Google Scholar
• Sornchai S, Warachit W, Lolekha P, Kosuwan P, Sutra S, Tanthiphabha B, Sutra S, Chup-Upprakarn S, Bock HL, Kosuwan P. Effect of climatic factors and population density on varicella zoster virus epidemiology within a tropical country. Am J Trop Med Hyg. 2001;64(3):131–6. doi:10.4269/ajtmh.2001.64.131.
   PubMed Web of Science ®Google Scholar
• Panatto D, Bragazzi NL, Rizzitelli E, Bonanni P, Boccalini S, Icardi G, Gasparini R, Amicizia D. Evaluation of the economic burden of Herpes Zoster (HZ) infection. Hum Vaccines Immunother. 2015;11(1):245–62. doi:10.4161/hv.36160.
   PubMed Web of Science ®Google Scholar
• Yin D, Van Oorschot D, Jiang N, Marijam A, Saha D, Wu Z, Tang H, Diaz-Decaro J, Watson P, Xie X, et al. A systematic literature review to assess the burden of herpes zoster disease in China. Exp Rev Anti-Infect Ther. 2021;19(2):165–79. doi:10.1080/14787210.2020.1792290.
   PubMed Web of Science ®Google Scholar
• Oxman MN, Levin MJ, Johnson GR, Schmader KE, Straus SE, Gelb LD, Arbeit RD, Simberkoff MS, Gershon AA, Davis LE, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med. 2005;352(22):2271–84. doi:10.1056/NEJMoa051016.
   PubMed Web of Science ®Google Scholar
• Willis ED, Woodward M, Brown E, Popmihajlov Z, Saddier P, Annunziato PW, et al. Herpes zoster vaccine live: a 10 year review of post-marketing safety experience. Vaccine. 2017;35:7231–9. doi:10.1016/j.vaccine.2017.11.013.
   PubMed Web of Science ®Google Scholar
• Thompson RR, Kong CL, Porco TC, Kim E, Ebert CD, Acharya NR. Herpes zoster and postherpetic neuralgia: changing incidence rates from 1994 to 2018 in the United States. Clini Infect Dis. 2021;73(9):e3210–e7. doi:10.1093/cid/ciaa1185.
   PubMed Web of Science ®Google Scholar
• Lal H, Cunningham AL, Godeaux O, Chlibek R, Diez-Domingo J, Hwang SJ, Levin MJ, McElhaney JE, Poder A, Puig-Barberà J, et al. Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults. N Engl J Med. 2015;372(22):2087–96. doi:10.1056/NEJMoa1501184.
   PubMed Web of Science ®Google Scholar
• Boutry C, Hastie A, Diez-Domingo J, Tinoco JC, Yu CJ, Andrews C, Beytout J, Caso C, Cheng H-S, Cheong HJ, et al. The adjuvanted recombinant zoster vaccine confers long-term protection against herpes zoster: interim results of an extension study of the pivotal phase 3 Clinical trials ZOE-50 and ZOE-70. Clin Infect Dis. 2022;74(8):1459–67. doi:10.1093/cid/ciab629.
   PubMed Web of Science ®Google Scholar
• Yang Q, Chang A, Tong X, Merritt R. Herpes zoster vaccine live and risk of stroke among medicare beneficiaries: a population-based cohort study. Stroke. 2021;52(5):1712–21. doi:10.1161/STROKEAHA.120.032788.
   PubMed Web of Science ®Google Scholar
• Bastidas A, de la Serna J, El Idrissi M, Oostvogels L, Quittet P, Lopez-Jimenez J, Vural F, Pohlreich D, Zuckerman T, Issa NC, et al. Effect of recombinant zoster vaccine on incidence of herpes zoster after autologous stem cell transplantation: a randomized Clinical trial. JAMA. 2019;322(2):123–33. doi:10.1001/jama.2019.9053.
   PubMed Web of Science ®Google Scholar
• Anderson TC, Masters NB, Guo A, Shepersky L, Leidner AJ, Lee GM, Kotton CN, Dooling KL. Use of recombinant zoster vaccine in immunocompromised adults aged ≥19 years: recommendations of the advisory committee on immunization practices — United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71(3):80–4. doi:10.15585/mmwr.mm7103a2.
   PubMed Web of Science ®Google Scholar
• Jiang B, Wang Q, Wang Z, Xu Y, Yang T, Yang W, Jia M, Feng L. Willingness to accept herpes zoster vaccines and the influencing factors in China. BMC Infect Dis. 2022;22(1):888. doi:10.1186/s12879-022-07840-2.
   PubMed Web of Science ®Google Scholar
• Lahariya C, Bhardwaj P. Adult vaccination in India: status and the way forward. Hum Vaccin Immunother. 2020;16:1508–10. doi:10.1080/21645515.2019.1692564.
   PubMed Web of Science ®Google Scholar
• Lahariya C. ‘Ayushman Bharat’ program and universal Health coverage in India. Indian Pediatr. 2018;55(6):495–506. doi:10.1007/s13312-018-1341-1.
   PubMed Web of Science ®Google Scholar
• Lahariya C. Health & wellness centers to strengthen primary Health care in India: concept, progress and ways forward. Indian J Pediatr. 2020;87(11):916–29. doi:10.1007/s12098-020-03359-z.
   PubMed Web of Science ®Google Scholar